A Study of Concomitant Camrelizumab With Chemoradiation for Locally Advanced Head and Neck Cancer

NCT04405154 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Neoplasms

Interventions

BIOLOGICAL: Camrelizumab
DRUG: Cisplatin
RADIATION: IMRT or VMAT

Sponsor

West China Hospital